In the EMA statement from today they said: > there is no evidence of a problem related to specific batches of the vaccine or to particular manufacturing sites;

In the EMA statement from today they said: > there is no evidence of a problem related to specific batches of the vaccine or to particular manufacturing sites; https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazene...